Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Share Migration

28 Mar 2013 16:15

RNS Number : 1999B
TyraTech, Inc.
28 March 2013
 



28 March 2013

 

 

TYRATECH, INC.

("TyraTech" or the "Company")

 

Migration of Shares

 

TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, announces that certain of its common shares of US$0.001 in the Company ("Common Shares"), which trade on the Company's restricted trading line under TIDM 'TYR' with ISIN number USU890581080, may now be eligible to migrate to the Company's unrestricted trading line under TIDM 'TYRU' with ISIN number US90239R2031.

 

Removal of the trading restrictions allows the shares to be:

 

·; transferred to its unrestricted trading line (TIDM: TYRU); and

·; settled (at the election of the shareholder), by means of Depositary Interests, through the CREST electronic settlement system.

 

TyraTech currently has a total of 108,176,305 Common Shares in issue, of which 1,084,413 are held in Treasury. 80,874,936 Common Shares trade under TIDM 'TYR' in a restricted manner as permitted by Regulation S promulgated under the U.S. Securities Act of 1933 (as amended). The Company's remaining 27,301,369 Common Shares in issue are unrestricted and trade under TIDM 'TYRU'. TyraTech believe that approximately 40.4 million of its Common Shares are currently eligible to migrate to the unrestricted line of shares.

 

In general, under U.S. securities law, Common Shares that have been in issue for more than one year and are not held by an 'affiliate' of the Company qualify for characterisation as unrestricted Common Shares ("Unrestricted Common Shares"). An affiliate for this purpose is a person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the Company or a director or officer of the Company. Generally a beneficial owner of 10% of more of the issued Common Shares taking into account shares held and any options, warrants or other securities convertible or exercisable within 60 days will be considered an affiliate for this purpose.

 

All Unrestricted Common Shares are eligible for migration to, and trading on, the Company's unrestricted TYRU line.

 

All Common Shares not meeting the definition of Unrestricted Common Shares will continue to trade in a restricted manner under the Company's TYR line. There is no difference in entitlement between the Common Shares trading in the restricted line and those trading in the unrestricted line, but the TYRU line will serve to evidence the absence of restrictions on trading otherwise imposed by the U.S. Securities Act of 1933 (as amended) and will enable electronic settlement if a holder so desires.

 

The Company has sent letters with instructions to shareholders whose Common Shares it believes should be eligible for migration ("Eligible Shares") to the Company's unrestricted TYRU line.

 

To participate, holders of Eligible Shares must deliver their current restricted share certificates to the Company's transfer agent (Computershare Investor Services (Jersey) Limited, Queensway House, Hilgrove Street, St Helier, Jersey, JE1 1ES) together with the Letter of Transmittal which has also been sent to holders of Eligible Shares, by 3 May 2013. Holders of Eligible Shares will have the option to either receive an unrestricted certificate in return or have their Eligible Shares entered into CREST, which is a depositary interest facility that permits trading on the unrestricted TYRU line to be settled electronically. 

 

Shareholders in the Company who already hold unrestricted paper certificates can apply to have their certificates entered into CREST by completing a dematerialisation form and sending it to Computershare.

 

Copies of the letter to shareholders and the Letter of Transmittal (for eligible shareholders with restricted shares) and dematerialisation forms (for shareholders with unrestricted paper shares who wish to transfer to CREST) will be made available on the Company's website, www.tyratech.com.

 

 

For further information please contact:

 

TyraTech Inc.Alan Reade, Executive ChairmanTel: +1 919 415 4310

 

Bruno Jactel, Chief Executive Officer

Tel: +1 919 415 4280

 

N+1 Singer, Nominated Adviser and Joint BrokerAubrey Powell / Alex WrightTel: +44 20 7496 3000

 

First Columbus LLP, Joint BrokerChris CrawfordTel: +44 20 3002 2070

 

Walbrook, Financial PR and IR

Bob Huxford / Paul Cornelius / Guy McDougall

Tel + 44 20 7933 8792

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKDPAFLDEFF
Date   Source Headline
29th Sep 20107:00 amRNSInterim Results
9th Sep 20109:46 amRNSNotice of Interim Results
25th Aug 20104:50 pmRNSUnrestricted Trading Line Completed
5th Aug 20107:00 amRNSBoard Change
29th Jul 20102:40 pmRNSMajor Interest in Shares
19th Jul 20107:00 amRNSEstablishing Unrestricted Trading Line
9th Jul 201012:41 pmRNSResult of AGM and Board Changes
23rd Jun 20104:06 pmRNSMajor Interest in Shares
22nd Jun 20107:00 amRNSResults for the year ended 31 December 2009
21st May 20105:35 pmRNSDirectors' Disclosure
19th May 20105:15 pmRNSResult of Special Meeting
18th May 20107:00 amRNSUpdate to Fundraising
10th May 20107:00 amRNSFundraising and Trading Update
29th Apr 20107:00 amRNSProspective fundraising of approximately £1m
24th Feb 20107:00 amRNSPreliminary Results
4th Feb 20105:41 pmRNSAward of Share Options
4th Feb 20107:00 amRNSExpanded Terminix Agreement
5th Jan 20107:00 amRNSBoard Changes
24th Nov 20097:00 amRNSTrading Update
11th Nov 20097:00 amRNSDirector Share Purchase
9th Nov 20097:00 amRNSArysta Insecticide Product Launch
5th Oct 20097:00 amRNSKraft Milestone and Contract
21st Sep 20093:41 pmRNSDirector Share Purchase
16th Sep 20097:01 amRNSBoard Changes
16th Sep 20097:01 amRNSChange of Auditor
16th Sep 20097:00 amRNSInterim Results
10th Sep 20097:00 amRNSClarke Partnership
19th Aug 20097:00 amRNSStrategic Partnership Agreement
28th Jul 20097:00 amRNSNew Product Launch
23rd Jul 20097:00 amRNSTrading Update
22nd Jun 20092:03 pmRNSAnnual Report and Accounts
21st May 200912:15 pmRNSAGM Statement
20th May 20097:00 amRNSExpanded Agreement with Terminix
20th Apr 20097:00 amRNSTerminix First Shipment
16th Apr 20096:02 pmRNSDirectors Share Purchase
15th Apr 20096:20 pmRNSDIRECTORS SHARE PURCHASE
14th Apr 20095:44 pmRNSDirectors Share Purchase
9th Apr 20095:17 pmRNSDirector Share Dealings
7th Apr 20095:00 pmRNSCorrected Notice of AGM
1st Apr 20097:06 amRNSPreliminary Results
30th Mar 20097:00 amRNSNew product Launches
20th Mar 20097:00 amRNSNotice of Preliminary Results
27th Jan 20097:00 amRNSShare Buy Back Transaction
16th Jan 20097:04 amRNSOptions Award
16th Jan 20097:02 amRNSShare Buy Back
16th Jan 20097:00 amRNSSalary Reductions
14th Jan 20097:00 amRNSNew Joint Venture - TyraChem
23rd Dec 20087:00 amRNSProgress with Kraft Foods Partnership
24th Nov 20087:00 amRNSAgreement Signed with Terminix
20th Oct 20087:00 amRNSSummons from Molecular Securities, Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.